Rosh Kumar Viasha Sethi, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 22 | 2024 | 2894 | 2.150 |
Why?
|
Hospital Costs | 4 | 2019 | 947 | 1.050 |
Why?
|
Laryngectomy | 5 | 2020 | 243 | 1.020 |
Why?
|
Rhinoplasty | 2 | 2019 | 238 | 0.990 |
Why?
|
Neck Injuries | 2 | 2019 | 160 | 0.980 |
Why?
|
Parotid Gland | 3 | 2024 | 176 | 0.920 |
Why?
|
Emergency Service, Hospital | 12 | 2020 | 7865 | 0.880 |
Why?
|
Otolaryngology | 8 | 2018 | 693 | 0.840 |
Why?
|
Carcinoma, Squamous Cell | 8 | 2024 | 4021 | 0.820 |
Why?
|
Sarcoma, Kaposi | 1 | 2024 | 374 | 0.720 |
Why?
|
Adenoidectomy | 1 | 2022 | 167 | 0.720 |
Why?
|
Pain, Postoperative | 3 | 2019 | 1741 | 0.690 |
Why?
|
Skin Neoplasms | 4 | 2024 | 5809 | 0.670 |
Why?
|
Analgesics, Opioid | 4 | 2019 | 3805 | 0.650 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2023 | 491 | 0.650 |
Why?
|
Surgical Flaps | 8 | 2023 | 1670 | 0.640 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2020 | 119 | 0.640 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1668 | 0.630 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 218 | 0.620 |
Why?
|
Fractures, Closed | 1 | 2019 | 88 | 0.610 |
Why?
|
Fractures, Open | 1 | 2019 | 107 | 0.590 |
Why?
|
Papillomavirus Infections | 4 | 2023 | 1616 | 0.560 |
Why?
|
Punctures | 2 | 2017 | 366 | 0.550 |
Why?
|
Epistaxis | 1 | 2017 | 112 | 0.540 |
Why?
|
Parotid Neoplasms | 1 | 2018 | 157 | 0.540 |
Why?
|
Hemostatic Techniques | 1 | 2017 | 111 | 0.530 |
Why?
|
Paranasal Sinuses | 1 | 2018 | 265 | 0.520 |
Why?
|
Health Care Costs | 4 | 2023 | 3239 | 0.520 |
Why?
|
Hearing Loss, Sensorineural | 3 | 2018 | 781 | 0.470 |
Why?
|
Laryngeal Diseases | 1 | 2017 | 243 | 0.470 |
Why?
|
Economic Competition | 2 | 2014 | 219 | 0.470 |
Why?
|
Free Tissue Flaps | 4 | 2024 | 331 | 0.460 |
Why?
|
Voice | 1 | 2017 | 268 | 0.460 |
Why?
|
Pharyngeal Neoplasms | 1 | 2014 | 113 | 0.460 |
Why?
|
Larynx | 1 | 2019 | 492 | 0.450 |
Why?
|
Laryngeal Neoplasms | 2 | 2015 | 514 | 0.450 |
Why?
|
Larynx, Artificial | 1 | 2014 | 69 | 0.450 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 2014 | 97 | 0.430 |
Why?
|
Carcinoma | 3 | 2014 | 2330 | 0.430 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1130 | 0.420 |
Why?
|
Neurites | 1 | 2014 | 391 | 0.410 |
Why?
|
Rhinitis | 2 | 2018 | 747 | 0.400 |
Why?
|
Endoscopy | 2 | 2018 | 1852 | 0.390 |
Why?
|
Esophagus | 1 | 2017 | 1036 | 0.390 |
Why?
|
Trachea | 1 | 2017 | 1090 | 0.380 |
Why?
|
Retrospective Studies | 40 | 2024 | 80675 | 0.380 |
Why?
|
Paraganglioma | 1 | 2013 | 143 | 0.380 |
Why?
|
Minocycline | 1 | 2012 | 169 | 0.380 |
Why?
|
Models, Educational | 1 | 2014 | 373 | 0.380 |
Why?
|
Hyperpigmentation | 1 | 2012 | 116 | 0.370 |
Why?
|
Hospitals | 5 | 2023 | 3881 | 0.370 |
Why?
|
Sinusitis | 2 | 2018 | 990 | 0.360 |
Why?
|
SEER Program | 3 | 2020 | 1453 | 0.350 |
Why?
|
Medicare | 4 | 2023 | 6774 | 0.350 |
Why?
|
United States | 32 | 2024 | 72341 | 0.340 |
Why?
|
Craniocerebral Trauma | 1 | 2014 | 491 | 0.340 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 304 | 0.330 |
Why?
|
Neck Dissection | 3 | 2019 | 201 | 0.320 |
Why?
|
Insurance Coverage | 5 | 2020 | 1935 | 0.320 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2018 | 324 | 0.300 |
Why?
|
Humans | 90 | 2024 | 761222 | 0.300 |
Why?
|
Neural Stem Cells | 1 | 2014 | 886 | 0.280 |
Why?
|
Middle Aged | 48 | 2024 | 220858 | 0.280 |
Why?
|
Aged | 40 | 2024 | 169292 | 0.280 |
Why?
|
Postoperative Complications | 6 | 2020 | 15637 | 0.280 |
Why?
|
Cochlear Implantation | 2 | 2023 | 316 | 0.280 |
Why?
|
Male | 62 | 2024 | 360703 | 0.280 |
Why?
|
Cochlear Implants | 2 | 2023 | 339 | 0.280 |
Why?
|
Female | 64 | 2024 | 392552 | 0.280 |
Why?
|
Hippocampus | 1 | 2019 | 3754 | 0.270 |
Why?
|
Inpatients | 1 | 2018 | 2545 | 0.270 |
Why?
|
Otitis Media | 2 | 2019 | 286 | 0.270 |
Why?
|
Pharyngectomy | 2 | 2017 | 44 | 0.270 |
Why?
|
Negotiating | 2 | 2024 | 151 | 0.260 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2020 | 1186 | 0.260 |
Why?
|
Head | 2 | 2023 | 922 | 0.250 |
Why?
|
Thyroid Nodule | 1 | 2012 | 763 | 0.250 |
Why?
|
Internship and Residency | 5 | 2018 | 5885 | 0.240 |
Why?
|
Surgicenters | 1 | 2024 | 50 | 0.230 |
Why?
|
Mouth Neoplasms | 2 | 2020 | 596 | 0.230 |
Why?
|
Glioma | 1 | 2019 | 3452 | 0.230 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2019 | 732 | 0.230 |
Why?
|
Adult | 36 | 2024 | 221120 | 0.220 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2013 | 1228 | 0.220 |
Why?
|
Hospitalization | 4 | 2020 | 10707 | 0.210 |
Why?
|
Papillomaviridae | 4 | 2023 | 1120 | 0.210 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1920 | 0.210 |
Why?
|
Osteoradionecrosis | 1 | 2022 | 51 | 0.200 |
Why?
|
Adolescent | 20 | 2023 | 88300 | 0.200 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3354 | 0.190 |
Why?
|
Middle Ear Ventilation | 1 | 2022 | 101 | 0.190 |
Why?
|
Nasolacrimal Duct | 1 | 2022 | 79 | 0.190 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2022 | 101 | 0.180 |
Why?
|
Medicare Part B | 1 | 2022 | 117 | 0.180 |
Why?
|
Child | 16 | 2022 | 80154 | 0.180 |
Why?
|
Surgical Stomas | 1 | 2020 | 42 | 0.180 |
Why?
|
Child, Preschool | 13 | 2020 | 42225 | 0.180 |
Why?
|
Young Adult | 16 | 2020 | 59222 | 0.180 |
Why?
|
Massachusetts | 4 | 2019 | 8837 | 0.170 |
Why?
|
Melanoma | 1 | 2018 | 5694 | 0.170 |
Why?
|
Triage | 2 | 2024 | 985 | 0.160 |
Why?
|
Thyroid Neoplasms | 1 | 2012 | 2330 | 0.160 |
Why?
|
Endovascular Procedures | 1 | 2013 | 2181 | 0.160 |
Why?
|
Hyperacusis | 1 | 2019 | 31 | 0.160 |
Why?
|
Preoperative Care | 2 | 2018 | 2241 | 0.160 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26072 | 0.160 |
Why?
|
Logistic Models | 7 | 2020 | 13249 | 0.160 |
Why?
|
Job Application | 1 | 2018 | 38 | 0.160 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58952 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20588 | 0.160 |
Why?
|
Labyrinthitis | 1 | 2018 | 32 | 0.160 |
Why?
|
Mastoiditis | 1 | 2018 | 37 | 0.150 |
Why?
|
Salvage Therapy | 3 | 2021 | 1264 | 0.150 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 3200 | 0.150 |
Why?
|
Cohort Studies | 10 | 2024 | 41496 | 0.150 |
Why?
|
Treatment Outcome | 17 | 2021 | 64681 | 0.150 |
Why?
|
Brain Abscess | 1 | 2018 | 120 | 0.150 |
Why?
|
HIV Infections | 1 | 2024 | 17348 | 0.140 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 225 | 0.140 |
Why?
|
Cell Differentiation | 1 | 2014 | 11512 | 0.140 |
Why?
|
Ranula | 1 | 2017 | 10 | 0.140 |
Why?
|
Audiometry | 1 | 2018 | 253 | 0.140 |
Why?
|
Jugular Veins | 1 | 2018 | 210 | 0.140 |
Why?
|
Combined Modality Therapy | 4 | 2017 | 8519 | 0.140 |
Why?
|
Meningitis | 1 | 2018 | 217 | 0.140 |
Why?
|
Qualitative Research | 2 | 2024 | 3024 | 0.140 |
Why?
|
After-Hours Care | 1 | 2017 | 101 | 0.130 |
Why?
|
Personnel Selection | 1 | 2018 | 196 | 0.130 |
Why?
|
Tinnitus | 1 | 2019 | 196 | 0.130 |
Why?
|
Surgery, Plastic | 1 | 2023 | 640 | 0.130 |
Why?
|
Neuroma, Acoustic | 1 | 2020 | 458 | 0.130 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 262 | 0.130 |
Why?
|
Tracheostomy | 1 | 2020 | 426 | 0.130 |
Why?
|
Multivariate Analysis | 5 | 2018 | 12052 | 0.130 |
Why?
|
Neck | 1 | 2020 | 734 | 0.130 |
Why?
|
Device Approval | 1 | 2017 | 163 | 0.130 |
Why?
|
Glossectomy | 1 | 2015 | 60 | 0.120 |
Why?
|
Clavicle | 2 | 2015 | 224 | 0.120 |
Why?
|
Education, Medical, Graduate | 3 | 2017 | 2374 | 0.120 |
Why?
|
Diagnostic Techniques, Otological | 1 | 2015 | 11 | 0.120 |
Why?
|
Supratentorial Neoplasms | 2 | 2013 | 159 | 0.120 |
Why?
|
Auditory Brain Stem Implants | 1 | 2014 | 33 | 0.120 |
Why?
|
Surgery, Computer-Assisted | 1 | 2022 | 1003 | 0.120 |
Why?
|
Acetaminophen | 1 | 2019 | 555 | 0.120 |
Why?
|
Neoplasm Staging | 6 | 2024 | 11119 | 0.120 |
Why?
|
Speech Disorders | 1 | 2015 | 180 | 0.120 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12976 | 0.120 |
Why?
|
Facial Paralysis | 1 | 2018 | 346 | 0.120 |
Why?
|
Medically Uninsured | 1 | 2019 | 834 | 0.110 |
Why?
|
Area Under Curve | 1 | 2018 | 1636 | 0.110 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 39 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9278 | 0.110 |
Why?
|
Telephone | 1 | 2017 | 624 | 0.110 |
Why?
|
Prognosis | 6 | 2024 | 29688 | 0.110 |
Why?
|
Insurance, Health | 3 | 2022 | 2493 | 0.110 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2913 | 0.110 |
Why?
|
Tongue Neoplasms | 1 | 2015 | 183 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1598 | 0.110 |
Why?
|
Hospitals, Teaching | 1 | 2018 | 1155 | 0.110 |
Why?
|
Ear Diseases | 1 | 2015 | 181 | 0.110 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2017 | 454 | 0.100 |
Why?
|
Forecasting | 2 | 2020 | 2928 | 0.100 |
Why?
|
Infant | 10 | 2020 | 36170 | 0.100 |
Why?
|
Neuroectodermal Tumors, Primitive | 1 | 2013 | 136 | 0.100 |
Why?
|
Stethoscopes | 1 | 2012 | 30 | 0.100 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2014 | 242 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1834 | 0.100 |
Why?
|
Hearing Loss | 1 | 2019 | 782 | 0.100 |
Why?
|
Acute Disease | 3 | 2018 | 7226 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2018 | 1303 | 0.100 |
Why?
|
Bibliometrics | 1 | 2015 | 352 | 0.090 |
Why?
|
Referral and Consultation | 1 | 2024 | 3608 | 0.090 |
Why?
|
Costs and Cost Analysis | 3 | 2023 | 1664 | 0.090 |
Why?
|
Models, Organizational | 1 | 2014 | 544 | 0.090 |
Why?
|
Accreditation | 1 | 2014 | 473 | 0.090 |
Why?
|
Rhabdoid Tumor | 1 | 2013 | 210 | 0.090 |
Why?
|
Coculture Techniques | 1 | 2014 | 1334 | 0.090 |
Why?
|
Arteries | 1 | 2015 | 1121 | 0.090 |
Why?
|
Risk Assessment | 6 | 2019 | 24022 | 0.090 |
Why?
|
Ependymoma | 1 | 2013 | 320 | 0.090 |
Why?
|
Ophthalmology | 1 | 2017 | 550 | 0.090 |
Why?
|
ROC Curve | 1 | 2018 | 3584 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1141 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2827 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1201 | 0.090 |
Why?
|
Multiple Organ Failure | 1 | 2012 | 386 | 0.090 |
Why?
|
Disinfection | 1 | 2012 | 207 | 0.090 |
Why?
|
Teratoma | 1 | 2013 | 404 | 0.090 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5493 | 0.080 |
Why?
|
Memory | 1 | 2019 | 2190 | 0.080 |
Why?
|
Radiotherapy, Conformal | 1 | 2013 | 548 | 0.080 |
Why?
|
Deglutition Disorders | 1 | 2015 | 627 | 0.080 |
Why?
|
Ischemia | 1 | 2018 | 1889 | 0.080 |
Why?
|
Patient Preference | 1 | 2017 | 927 | 0.080 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3590 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1401 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1662 | 0.080 |
Why?
|
Registries | 3 | 2020 | 8246 | 0.080 |
Why?
|
Survivors | 1 | 2019 | 2369 | 0.080 |
Why?
|
Ulnar Nerve | 1 | 1989 | 102 | 0.080 |
Why?
|
Surgical Wound Infection | 1 | 2018 | 1530 | 0.080 |
Why?
|
Urination Disorders | 1 | 1989 | 238 | 0.080 |
Why?
|
Cerebellar Neoplasms | 1 | 2013 | 586 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7804 | 0.080 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 730 | 0.080 |
Why?
|
Medulloblastoma | 1 | 2013 | 677 | 0.070 |
Why?
|
Publishing | 1 | 2015 | 832 | 0.070 |
Why?
|
Disease-Free Survival | 4 | 2021 | 6819 | 0.070 |
Why?
|
Linear Models | 2 | 2019 | 5869 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2016 | 6223 | 0.070 |
Why?
|
Brain Concussion | 1 | 2019 | 1404 | 0.070 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2013 | 1784 | 0.070 |
Why?
|
Reflex | 1 | 1989 | 374 | 0.070 |
Why?
|
Motor Neurons | 2 | 1989 | 869 | 0.070 |
Why?
|
Patient Admission | 1 | 2015 | 1365 | 0.070 |
Why?
|
Biopsy, Fine-Needle | 1 | 2012 | 1118 | 0.070 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 785 | 0.070 |
Why?
|
Brachial Plexus | 1 | 1989 | 168 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3727 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1304 | 0.070 |
Why?
|
Survival Rate | 3 | 2019 | 12728 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11733 | 0.070 |
Why?
|
Thyroidectomy | 1 | 2012 | 908 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1275 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2813 | 0.070 |
Why?
|
Graft Survival | 2 | 2014 | 3843 | 0.070 |
Why?
|
Tissue and Organ Procurement | 1 | 2014 | 963 | 0.070 |
Why?
|
Thyroid Gland | 1 | 2012 | 1169 | 0.060 |
Why?
|
Patient Selection | 2 | 2014 | 4246 | 0.060 |
Why?
|
Propensity Score | 1 | 2013 | 1916 | 0.060 |
Why?
|
Chronic Disease | 2 | 2018 | 9319 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2019 | 5295 | 0.060 |
Why?
|
Age Factors | 2 | 2018 | 18384 | 0.060 |
Why?
|
Central Nervous System Neoplasms | 1 | 2013 | 915 | 0.060 |
Why?
|
Health Surveys | 1 | 2014 | 4037 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3051 | 0.060 |
Why?
|
Fees and Charges | 1 | 2024 | 192 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 7965 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 1789 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14610 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14675 | 0.050 |
Why?
|
Cross Infection | 1 | 2012 | 1422 | 0.050 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2024 | 392 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39127 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5426 | 0.050 |
Why?
|
Morbidity | 2 | 2019 | 1751 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1940 | 0.050 |
Why?
|
Length of Stay | 3 | 2020 | 6417 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15841 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4481 | 0.050 |
Why?
|
Odds Ratio | 1 | 2013 | 9652 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3741 | 0.040 |
Why?
|
Leuprolide | 1 | 2022 | 312 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2018 | 22174 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20118 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11067 | 0.040 |
Why?
|
Myoglobinuria | 1 | 1999 | 22 | 0.040 |
Why?
|
Frozen Sections | 1 | 2020 | 153 | 0.040 |
Why?
|
Electric Injuries | 1 | 1999 | 24 | 0.040 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2024 | 463 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3434 | 0.040 |
Why?
|
Humidity | 1 | 2020 | 205 | 0.040 |
Why?
|
Infant, Newborn | 5 | 2020 | 26200 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2014 | 4242 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4788 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 934 | 0.040 |
Why?
|
Quality of Life | 2 | 2024 | 13367 | 0.040 |
Why?
|
Hospital Charges | 1 | 2020 | 350 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2012 | 3885 | 0.040 |
Why?
|
Growth Disorders | 1 | 2022 | 634 | 0.040 |
Why?
|
Forearm | 1 | 2020 | 427 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15721 | 0.040 |
Why?
|
Hematocrit | 1 | 2018 | 623 | 0.030 |
Why?
|
Protons | 1 | 2022 | 1111 | 0.030 |
Why?
|
Parotid Diseases | 1 | 2017 | 49 | 0.030 |
Why?
|
Incidence | 3 | 2020 | 21366 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2697 | 0.030 |
Why?
|
DNA, Viral | 1 | 2023 | 2195 | 0.030 |
Why?
|
Equipment Safety | 1 | 2017 | 249 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2018 | 525 | 0.030 |
Why?
|
Risk Factors | 4 | 2017 | 74241 | 0.030 |
Why?
|
Reoperation | 2 | 2018 | 4303 | 0.030 |
Why?
|
Cost Savings | 1 | 2021 | 911 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2018 | 436 | 0.030 |
Why?
|
Cause of Death | 2 | 2019 | 3688 | 0.030 |
Why?
|
Hospitals, Pediatric | 2 | 2017 | 1862 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2018 | 680 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9429 | 0.030 |
Why?
|
Health Personnel | 2 | 2023 | 3337 | 0.030 |
Why?
|
Speech Intelligibility | 1 | 2015 | 79 | 0.030 |
Why?
|
Limb Salvage | 1 | 2018 | 480 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2024 | 6067 | 0.030 |
Why?
|
Laminin | 1 | 1996 | 407 | 0.030 |
Why?
|
Electromyography | 2 | 1989 | 1393 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10553 | 0.030 |
Why?
|
Pharynx | 1 | 2017 | 432 | 0.030 |
Why?
|
Hot Temperature | 1 | 2020 | 1434 | 0.030 |
Why?
|
Muscular Dystrophies | 1 | 1996 | 391 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1818 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10088 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22142 | 0.030 |
Why?
|
Gastrostomy | 1 | 2015 | 323 | 0.030 |
Why?
|
Infratentorial Neoplasms | 1 | 2013 | 98 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2013 | 9025 | 0.020 |
Why?
|
Duodenal Neoplasms | 1 | 2012 | 114 | 0.020 |
Why?
|
Drug Costs | 1 | 2020 | 1183 | 0.020 |
Why?
|
Muscles | 1 | 1996 | 1568 | 0.020 |
Why?
|
Income | 1 | 2020 | 1869 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2012 | 407 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2013 | 249 | 0.020 |
Why?
|
Leucovorin | 1 | 2012 | 643 | 0.020 |
Why?
|
Cranial Irradiation | 1 | 2013 | 390 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2277 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2425 | 0.020 |
Why?
|
Nausea | 1 | 2012 | 678 | 0.020 |
Why?
|
Workload | 1 | 2015 | 845 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 650 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2871 | 0.020 |
Why?
|
Camptothecin | 1 | 2012 | 591 | 0.020 |
Why?
|
Patients | 1 | 2015 | 906 | 0.020 |
Why?
|
Career Choice | 1 | 2014 | 757 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2175 | 0.020 |
Why?
|
Poverty | 1 | 2020 | 2691 | 0.020 |
Why?
|
Neural Conduction | 1 | 1989 | 441 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2510 | 0.020 |
Why?
|
Fluorouracil | 1 | 2012 | 1642 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3441 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 1999 | 1923 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1566 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54437 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 1989 | 352 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2013 | 2897 | 0.020 |
Why?
|
Central Nervous System | 1 | 2013 | 1333 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 20982 | 0.020 |
Why?
|
Neural Inhibition | 1 | 1989 | 586 | 0.020 |
Why?
|
Tissue Donors | 1 | 2014 | 2335 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2013 | 3512 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6486 | 0.010 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1989 | 709 | 0.010 |
Why?
|
Animals | 1 | 2014 | 168089 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15308 | 0.010 |
Why?
|
Action Potentials | 1 | 1989 | 1830 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7046 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12474 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2015 | 4822 | 0.010 |
Why?
|
Compartment Syndromes | 1 | 1999 | 159 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6341 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1996 | 684 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 39957 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13632 | 0.010 |
Why?
|
Heart Arrest | 1 | 1999 | 1513 | 0.010 |
Why?
|
Burns | 1 | 1999 | 1875 | 0.000 |
Why?
|